alpelisib
ItalyDrugs containing this active substance
-
It is used for the treatment of postmenopausal women and men with a type of breast cancer called hormone receptor (HR)-positive and HER2-negative advanced breast cancer, in the presence of a specific PIK3CA gene mutation and in combination with fulvestrant.
Form: tablets, film-coated
Active substance Dosage alpelisib - ATC: L01EM03
Manufacturer: NOVARTIS EUROPHARM LIMITED